← Back to Clinical Trials
Recruiting NCT07539519

NCT07539519 A Toolkit to Improve Mental Health Treatment for Autistic Individuals

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07539519
Status Recruiting
Phase —
Sponsor Florida International University
Condition Autism
Study Type INTERVENTIONAL
Enrollment 18 participants
Start Date 2026-04-09
Primary Completion 2027-12

Eligibility & Interventions

Sex All sexes
Min Age 13 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Enhanced PsychotherapyTreatment as Usual (TAU)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 18 participants in total. It began in 2026-04-09 with a primary completion date of 2027-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This pilot study is funded by the Organization for Autism Research (OAR). We are conducting a pilot study to improve mental health treatment for autistic individuals. First, we will conduct remote focus groups to identify barriers to mental health treatment and methods to improve treatment. Based on results, we will develop a prototype of a resource for therapists. This resource will be pilot tested in a community clinic.

Eligibility Criteria

The following describes Phase II (the clinical trial): Inclusion Criteria for clients: * A confirmed diagnosis of autism * Between 13 and 17 years old * Fluent in English * Have a co-occurring mental health condition that is appropriate for treatment at the community clinic participating in the proposed study Exclusion criteria: N/A All therapists working at the community clinic at which this study takes place will be eligible to participate.

Contact & Investigator

Central Contact

Yael Dai, PhD

✉ ydai@fiu.edu

📞 13053481034

Frequently Asked Questions

Who can join the NCT07539519 clinical trial?

This trial is open to participants of all sexes, aged 13 Years or older, studying Autism. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07539519 currently recruiting?

Yes, NCT07539519 is actively recruiting participants. Contact the research team at ydai@fiu.edu for enrollment information.

Where is the NCT07539519 trial being conducted?

This trial is being conducted at Miami, United States, Miami, United States.

Who is sponsoring the NCT07539519 clinical trial?

NCT07539519 is sponsored by Florida International University. The trial plans to enroll 18 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology